The specialist integrated CDMO

Browser not supported

Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:

Google Chrome
Safari
Firefox
Edge
© 2025 Hovione
  • Linkedin
  • Facebook
  • Twitter
  • Instagram
  • Youtube
search
    en
      pt jp cn
Hovione
Home Go up
  • Products and Services
      • Contract Manufacturing Services
        • Drug Substance
        • Particle Engineering
        • Drug Product
      • Off-patent API products
        • API Portfolio
        • Exclusive partnerships
        • High value applications
      • Supporting Capabilities
        • Analytical Support
        • Capabilities
        • Continuity of Supply
        • Quality and Compliance
  • Knowledge Center
  • About Us
      • About Hovione
        • What we do
        • Management
        • Sustainability
        • History
  • Contact Us
  • Press Room
  • Hovione Worldwide
  • Careers
  • Restricted Area

Search

Types

  • Article
  • Event

Press Room

  • Press Clipping
  • Article
  • News
  • Press Release

Categories

  • Hovione Loures
  • Hovione Cork
  • Hovione Mumbai
  • Hovione Japan
  • Hovione Lumiar
  • About Hovione
  • Hovione Macau
  • Homepage
  • Compliance
  • Hovione Lisboa
  • Sustainability
  • Analytical support
  • Business conduct
  • CMO
  • Continuous Manufacturing
  • Continuous Manufacturing
  • Contract Manufacturing Services
  • DP - Drug product
  • DS - Drug Substance
  • Hovione Switzerland
  • Off-patent API
  • PE - Spray drying
  • PPL - Proprietary Product Licensing
  • Proprietary Product Licensing Team
  • Quality
  • (-) Hovione New Jersey
  • (-) Management
View
News / Apr 08, 2021

Today we celebrate our 62nd Anniversary

April 8, 2021

View
Press Clipping / Mar 06, 2022

Hovione promotes Herbeaux to CEO

C&EN, 6 March 2022

View
Press Clipping / Nov 12, 2018

How Hovione grew from a basement lab to a global pharmaceutical services company

C&EN, November 12, 2018

View
Article / Nov 27, 2020

Europe’s drug supply chain gets ready for a makeover

C&EN, 20 May 2019

View
Press Release / Feb 25, 2022

Jean-Luc Herbeaux to become Hovione CEO

Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022

Pagination

  • First page « First
  • Previous page ‹‹
  • Page 1
  • Current page 2
Analytical Support
Quality and Compliance
Capabilities
Continuity of Supply
Track Record/cGMP Compliance
Regulatory Affairs
Continuity of Supply
  • Hovione Worldwide
  • Events
  • Press Room
  • Careers
  • Customers
  • Suppliers
Contacts
Lindenstrasse 14
6340 Baar
Switzerland
  • Linkedin
  • Facebook
  • Twitter
  • Instagram
  • Youtube
  • Privacy Notice
  • Terms and Conditions
    • Linkedin
    • Facebook
    • Twitter
    • Instagram
    • Youtube
  • Hovione Worldwide
  • Events
  • Press Room
  • Careers
  • Customers
  • Suppliers
  • Contacts
    Lindenstrasse 14
    6340 Baar
    Switzerland
    © 2025 Hovione
    © 2025 Hovione
    • Privacy Notice
    • Terms and Conditions